Inhibition of p300 and nuclear factor-κB by curcumin and its role in diabetic nephropathy

Nutrition

Volumn 25, Issue 9, 2009, Pages 973-974

  Kurien, Biji T ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CURCUMIN; DIMETHYL SULFOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HISTONE ACETYLTRANSFERASE PCAF; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; LETTER; NONHUMAN; OXIDATIVE STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CURCUMIN; DIABETIC NEPHROPATHIES; DIMETHYL SULFOXIDE; E1A-ASSOCIATED P300 PROTEIN; ETHANOL; NF-KAPPA B; PHYTOTHERAPY; RATS; VEHICLES;

EID: 67849121494     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.04.019     Document Type: Letter

References (11)

1. Chiu J., Khan Z.A., Farhangkhoee H., and Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 25 (2009) 964-972
2. Kurien B.T., Singh A., Matsumoto H., and Scofield R.H. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 5 (2007) 567-576
3. Kurien B.T., and Scofield R.H. Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification. Mol Nutr Food Res 53 (2009) 308
4. Kurien B.T., Jackson K., and Scofield R.H. Immunoblotting of multiple antigenic peptides. Electrophoresis 19 (1998) 1659-1661
5. Kurien B.T., and Scofield R.H. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants. J Immunol Methods 303 (2005) 66-75
6. Kurien B.T., and Scofield R.H. Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification-an in vitro study. J Ethnopharmacol 110 (2007) 368-373
7. Camici G.G., Steffel J., Akhmedov A., Schafer N., Baldinger J., Schulz U., et al. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 114 (2006) 1512-1521
8. Qi W., Ding D., and Salvi R.J. Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Hear Res 236 (2008) 52-60
9. Cao X.G., Li X.X., Bao Y.Z., Xing N.Z., and Chen Y. Responses of human lens epithelial cells to quercetin and DMSO. Invest Ophthalmol Vis Sci 48 (2007) 3714-3718
10. Nasrallah F.A., Garner B., Ball G.E., and Rae C. Modulation of brain metabolism by very low concentrations of the commonly used drug delivery vehicle dimethyl sulfoxide (DMSO). J Neurosci Res 86 (2008) 208-214
11. Kurien B.T., and Scofield R.H. Heat-solubilized curcumin should be considered in clinical trials for increasing bioavailability. Clin Cancer Res 15 (2009) 747